ES8601687A1 - Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph - Google Patents

Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph

Info

Publication number
ES8601687A1
ES8601687A1 ES531346A ES531346A ES8601687A1 ES 8601687 A1 ES8601687 A1 ES 8601687A1 ES 531346 A ES531346 A ES 531346A ES 531346 A ES531346 A ES 531346A ES 8601687 A1 ES8601687 A1 ES 8601687A1
Authority
ES
Spain
Prior art keywords
tablets
dipiridamol
dissemination
independent controlled
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES531346A
Other languages
English (en)
Spanish (es)
Other versions
ES531346A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Corp
Original Assignee
Boehringer Ingelheim Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Corp filed Critical Boehringer Ingelheim Corp
Publication of ES531346A0 publication Critical patent/ES531346A0/es
Publication of ES8601687A1 publication Critical patent/ES8601687A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
ES531346A 1983-04-08 1984-04-06 Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph Expired ES8601687A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48328583A 1983-04-08 1983-04-08

Publications (2)

Publication Number Publication Date
ES531346A0 ES531346A0 (es) 1985-11-01
ES8601687A1 true ES8601687A1 (es) 1985-11-01

Family

ID=23919470

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531346A Expired ES8601687A1 (es) 1983-04-08 1984-04-06 Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph

Country Status (20)

Country Link
EP (1) EP0121901B1 (enExample)
JP (1) JPS6034906A (enExample)
KR (1) KR880002139B1 (enExample)
AT (1) ATE32980T1 (enExample)
AU (1) AU570446B2 (enExample)
CA (1) CA1219216A (enExample)
DD (1) DD222496A5 (enExample)
DE (1) DE3469848D1 (enExample)
DK (1) DK166259C (enExample)
ES (1) ES8601687A1 (enExample)
FI (1) FI82604C (enExample)
GR (1) GR81907B (enExample)
HU (1) HU191542B (enExample)
IE (1) IE57220B1 (enExample)
IL (1) IL71458A (enExample)
NO (1) NO164958C (enExample)
NZ (1) NZ207768A (enExample)
PH (1) PH21585A (enExample)
PT (1) PT78380B (enExample)
ZA (1) ZA842562B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
BG860Y1 (bg) * 2004-09-17 2007-02-28 "Софарма" Ад Лекарствена форма на дипиридамол
EP1919460A2 (en) * 2005-08-22 2008-05-14 Novartis AG Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent
CA2671470C (en) 2006-12-13 2012-05-01 F. Hoffmann-La Roche Ag Powder formulation for valganciclovir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤

Also Published As

Publication number Publication date
DK166259B (da) 1993-03-29
PT78380A (en) 1984-05-01
DK181084A (da) 1984-10-09
ES531346A0 (es) 1985-11-01
IE57220B1 (en) 1992-06-03
GR81907B (enExample) 1984-12-12
EP0121901B1 (en) 1988-03-16
AU2660984A (en) 1984-10-11
NO841372L (no) 1984-10-09
HUT34345A (en) 1985-03-28
JPS6034906A (ja) 1985-02-22
KR840008588A (ko) 1984-12-17
PH21585A (en) 1987-12-11
IE840856L (en) 1984-10-08
DK181084D0 (da) 1984-04-06
FI82604B (fi) 1990-12-31
DK166259C (da) 1993-08-23
NO164958B (no) 1990-08-27
EP0121901A1 (en) 1984-10-17
PT78380B (en) 1986-08-14
CA1219216A (en) 1987-03-17
IL71458A0 (en) 1984-07-31
ATE32980T1 (de) 1988-04-15
AU570446B2 (en) 1988-03-17
JPH0521892B2 (enExample) 1993-03-25
DE3469848D1 (en) 1988-04-21
FI82604C (fi) 1991-04-10
NO164958C (no) 1990-12-05
KR880002139B1 (ko) 1988-10-17
NZ207768A (en) 1987-02-20
ZA842562B (en) 1985-12-24
IL71458A (en) 1987-09-16
HU191542B (en) 1987-03-30
DD222496A5 (de) 1985-05-22
FI841369L (fi) 1984-10-09
FI841369A0 (fi) 1984-04-06

Similar Documents

Publication Publication Date Title
ES2032755T3 (es) Medicamentos conteniendo hexadecil-fosfocolina con efecto antitumoral.
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
IS1363B6 (is) Framleiðsla á nýjum omeprazól-söltum
ES8101068A1 (es) Procedimiento para la preparacion de anilidas de acidos 4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilicos
GB1518843A (en) Process for the preparation of hollow particulates
ES8601687A1 (es) Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph
DE2963990D1 (en) Analgesic tablet and process for its preparation
ES551436A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina
ES8305684A1 (es) Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas.
NO306762B1 (no) Anvendelse av lanolinderivater sammen med polyetylenglykoletere, blanding derav og transdermalt terapeutisk system
IL82925A0 (en) Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them
JPS5420195A (en) Preparation of guanosine-5'-monophosphoric acid
JPS52130905A (en) Medicinal composition
JPS5283429A (en) Preparation of aromatic unsaturated carboxylic acid amide derivatives
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
AR240829A2 (es) Procedimiento para aislar levamisol de tetramisol
JPS53130619A (en) Preparation of high purity isoprenylacetic acid
JPS52106825A (en) Preparation of alkylphenols
JPS5273897A (en) Synthesis of pyrido 2,3_d pyrimidine derivatives
JPS5655360A (en) Optical resolution of (+-)-phenylglycine and/or (+-)-camphor-sulfonic acid
JPS5251378A (en) Preparation of 4(3h)-quinazolinone derivatives
JPS5352689A (en) Isolation of glutamic acid sodium salt
IL88349A0 (en) Substituted thienoimidazole derivatives,processes for their preparation,pharmaceutical preparations containing them and their use as inhibitors of gastric acid secretion
ES8307006A1 (es) Procedimiento de preparar nuevos derivados de aprovincaminol.
JPS5291896A (en) Preparation of 8-methylberbin derivatives